Institutionelle bei Genzyme

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Massachusetts Financial Services Co - Other 20,161,134 $429,633,765
Wellington Management Company 19,571,767 $417,074,354
Citigroup Inc. 19,114,176 $407,323,090
Barclays Bank Plc 6,064,677 $129,238,266
FMR Corporation (Fidelity Management & Research Corp) 4,616,283 $98,372,990
Putnam Investment Management, Inc. 4,570,981 $97,407,605
State Street Corporation 4,453,818 $94,910,861
Vanguard Group, Inc. (The) 4,056,983 $86,454,307
Fleetboston Financial Corporation 3,699,293 $78,831,933
Invesco Funds Group, Inc. 3,357,480 $71,547,898

Topliste der investierten Fonds
Smith Barney Aggressive Growth Fund Inc. 5,500,000 $117,205,000
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 4,786,524 $102,000,826
Vanguard Specialized-Health Care Fund 4,780,940 $101,881,831
Massachusetts Investors Growth Stock Fund 1,963,000 $41,831,530
MFS Mid Cap Growth Fund 1,972,300 $42,029,713
Janus Mercury Fund 1,844,495 $39,306,188
Vanguard Index 500 Fund 1,745,323 $37,192,833
College Retirement Equities Fund-Stock Account 1,620,955 $34,542,551
Eaton Vance Tax-Managed Growth Portfolio 1,575,812 $33,580,553
GCG Trust-Mid Cap Growth Series 1,380,000 $29,407,800